These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15496841)

  • 1. [Pharmacological correction of cochleovestibular impairments].
    Pal'chun VT; Poliakova TS; Kunel'skaia NA; Bogdanets SA
    Vestn Otorinolaringol; 2004; (4):36-9. PubMed ID: 15496841
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of effectiveness of treatment of cochleovestibular disorders with mildronate].
    Luchikhin LA; Pankova TB; Kakymov MI
    Vestn Otorinolaringol; 1991; (2):36-40. PubMed ID: 2048251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vestibo in the treatment of cochleovestibular disorders].
    Kunel'skaia NL; Levina IuV; Doronina OM; Krasiuk AA; Izotova GN
    Vestn Otorinolaringol; 2008; (6):52-4. PubMed ID: 19209416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Betaserk in therapy of cochleovestibular disordes].
    Khrapko NS; Sedykh MI; As'kova LN; Tarasova NV; Velikanov AK; Baryshevskaia LA
    Vestn Otorinolaringol; 2006; (4):59-60. PubMed ID: 17152479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Betaserk efficiency in cochlear and vestibular disorders in the regional surdocenter].
    Pekaskiĭ SI
    Vestn Otorinolaringol; 2001; (3):61. PubMed ID: 11510053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ischemic cochlear vestibular syndromes].
    Putilina MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(6):35-9. PubMed ID: 22983237
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of using tanakan in an ENT specialist's practice].
    Morozova SV
    Vestn Otorinolaringol; 2010; (4):87-9. PubMed ID: 21105354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cavinton in the treatment of cochleovestibular disorders of vascular genesis].
    Kunel'skaia NL; Gulieva AE; Ianiushkina ES; Chugunova MI
    Vestn Otorinolaringol; 2009; (5):52-4. PubMed ID: 20041504
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of betaserk in patients with cochlear-vestibular disorders].
    Kadymov MI; Poliakova TS; Vladimirova TN
    Vestn Otorinolaringol; 1998; (5):49-50. PubMed ID: 9793432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endaural reflex diagnosis of cochleovestibular dysfunctions in patients with vascular brain diseases].
    Troshin OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1996; 96(5):59-63. PubMed ID: 9012257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ginkgo biloba: local experiences.
    Hahn A; Stolbova K
    Int Tinnitus J; 2000; 6(1):54-5. PubMed ID: 14689619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The influence of Memoplant monotherapy on the dizziness].
    Kryukov AI; Kunel'skaya NL; Yanyushkina ES; Baybakova EV; Chugunova MA; Tardov MV; Zaoeva ZO; Izotova GN
    Vestn Otorinolaringol; 2017; 82(4):56-59. PubMed ID: 28980599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correction of autonomic sensory disorders in middle ear diseases].
    Morozova SV; Zaĭtseva OV
    Vestn Otorinolaringol; 2002; (3):38-41. PubMed ID: 12227028
    [No Abstract]   [Full Text] [Related]  

  • 14. [The Stennert antiphlogistic-rheologic infusion schema in treatment of cochleovestibular disorders].
    Michel O; Jahns T; Joost-Enneking M; Neugebauer P; Streppel M; Stennert E
    HNO; 2000 Mar; 48(3):182-8. PubMed ID: 10768108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intracranial hypertension and its role in the development of cochleovestibular disorders].
    Ivanets IV; Levina IuV; Eremeeva NV
    Vestn Otorinolaringol; 2009; (3):61-5. PubMed ID: 19708097
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of medical therapy in the prevention of residual dizziness after successful repositioning maneuvers for Benign Paroxysmal Positional Vertigo (BPPV).
    Acar B; Karasen RM; Buran Y
    B-ENT; 2015; 11(2):117-21. PubMed ID: 26563011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of monotreane in the treatment of patients with cochleovestibular disorders].
    Pal'chun VT; Kadymova MI; Kriukov AI
    Vestn Otorinolaringol; 1989; (5):20-2. PubMed ID: 2588407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Betaserc in the treatment of vestibular dysfunctions of different etiology].
    Nalimova TA; Kolenova IE
    Vestn Otorinolaringol; 2006; (1):57-8. PubMed ID: 16482015
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cochleovestibular manifestations in hypothyroidism].
    Ciges M; Dabbakh M; Sainz M
    Acta Otorrinolaringol Esp; 1989 Dec; 40 Suppl 2():232-5. PubMed ID: 2627514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Trimetazidine therapy in atrio-cochlear disturbances of vascular origin].
    Kozakiewicz K; Wróbel M; Petelenz T; Lepkowski A; Skrzypek-Wańha J; Chruściel TL
    Pol Tyg Lek; 1993 Apr 5-12; 48(14-15):327-9. PubMed ID: 8415248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.